Biography
Dr. Umang Swami is an Associate Professor of Medicine at Huntsman Cancer Institute, University of Utah, where he serves as Section Leader of the Genitourinary Disease Group and leads the Genitourinary Clinical Trials Research Group. He specializes in genitourinary cancers, with a focus on advancing innovative therapies through clinical and translational research. Dr. Swami earned his medical degree in India, completed his Internal Medicine residency in New York, and pursued Hematology-Oncology fellowship training and a Master of Science in Clinical Investigation at the University of Iowa. He is a Fellow of the American Society of Clinical Oncology (FASCO). He has authored over 180 publications and book chapters, serves on multiple ASCO guideline panels and NCCN Guidelines Panel for Bladder and Penile Cancer. He also serves as Editor-in-Chief of The International Journal of Cancer Care and Delivery (IJCCD), the official journal of Binaytara. An active clinical investigator, Dr. Swami is dedicated to advancing cancer research, improving patient outcomes, and mentoring future generations of oncologists.
Financial Disclosure
Pfizer
Consultant
Gilead
Consultant
Janssen
Consultant
Astellas
Consultant
Exelixis
Consultant
Seattle Genetics
Consultant
ImVax
Consultant
Sanofi
Consultant
AstraZeneca
Consultant
Adaptimmune
Consultant
Flatiron Health
Consultant
Kairos
Consultant
Merck
Consultant
research funding to the institute from AstraZeneca, Astellas/Seattle Genetics, Exelixis, Janssen, Lava Therapeutics, Loxo/Lilly, Merck, Novartis, ORIC Pharmaceuticals and Pfizer
Other